EULAR collaborates with consortia across Europe to help incorporate the patient perspective as well as advocacy and educational considerations in all stages of international research on rheumatic and musculoskeletal diseases (RMDs). This work is led by EULAR Research in collaboration with EULAR PARE (People with Arthritis and Rheumatism in Europe).

Interested consortia are invited to submit a collaboration request online.

Eligibility:

• Consortia and its topic must be rheumatology led or co-led.
• Consortia must be based in EULAR-affiliated countries.
• Consortia must apply for funding external to EULAR (e.g., Horizon Europe, Innovative Medicines Initiative, Innovative Health Initiative).
• Consortia must contact EULAR as soon as proposal development is initiated and with at least eight weeks in advance of proposal submission deadline.
• EULAR must be recognised as a full partner in the consortia (depending on the activities during the project, EULAR will determine the required budget to carry out these activities).
• Consortia must ensure the active engagement and equitable participation of patient research partners (PRPs) from the EULAR network in discussions from the start of the project’s design phase.
  

Terms and Conditions 

Support will depend on EULAR’s capacity to accommodate requests, as well as on the projects’ alignment to EULAR’s mission and community. Kindly note that due to the high volume of inquiries, there might be a delay in responding to collaboration requests. It is recommended to contact the EULAR Research team well in advance to maximize the likelihood of collaboration.

 Research Ethics  

EULAR expects a high standard in the conduct of research it supports. For researchers this includes scientific integrity and adherence to the principles of good research practice. Patients subjected to investigation shall be included with due adherence to the declaration of Helsinki.